08-18-2021, 06:59 AM
(This post was last modified: 08-18-2021, 07:00 AM by ken-do-nim.)
As for Moderna, no argument that the stock price is higher than the company's drug pipeline would indicate, but I'm holding on until at least full FDA approval. Should be there by the end of September. Also there is news about their HIV vaccine starting human trials. That's pretty exciting, though it's just phase 1.